Roopinder Gillmore
Verizon (United States)(US)Royal Free London NHS Foundation Trust(GB)The Royal Free Hospital(GB)University College London(GB)
Publications by Year
Research Areas
Pancreatic and Hepatic Oncology Research, Cholangiocarcinoma and Gallbladder Cancer Studies, Gallbladder and Bile Duct Disorders, Neuroendocrine Tumor Research Advances, Renal and related cancers
Most-Cited Works
- → Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial(2017)1,902 cited
- → Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study(2019)1,194 cited
- → Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial(2023)937 cited
- → Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial(2021)725 cited
- → EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolization(2011)323 cited